To What Extent Does Ozone Therapy Need a Real Biochemical Control System? Assessment and Importance of Oxidative Stress

Archives of Medical Research

Volumn 38, Issue 5, 2007, Pages 571-578

  Hernández, Frank Antonio ^a  

^a Ozone Research Center Havana   (Cuba)

Author keywords

Antioxidant enzymes; Antioxidant state; Oxidant state; Oxidative stress; Ozone therapy

Indexed keywords

ALDEHYDE DEHYDROGENASE; ALKADIENE; CATALASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; HYDROPEROXIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE; SUPEROXIDE DISMUTASE;

ARTICLE; BIOCHEMISTRY; BLOOD ANALYSIS; CHEMICAL ANALYSIS; CONTROL SYSTEM; HUMAN; OXIDATIVE STRESS; OZONE THERAPY;

EID: 34249897727     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2007.03.002     Document Type: Article

References (79)

1. Bocci B. Does ozone therapy normalize the cellular redox balance?. Med Hypoth 46 (1996) 150-154
2. Kontorschikova CN. Biochemical safety control in ozone therapy. Proceedings of the 12th World Congress of the International Ozone Association (Vol. 3). Lille, France; 1995. pp. 231-234.
3. Bocci V. The antioxidant system and the defence system against ozone. In: Bocci V. (Ed). Oxygen-Ozone Therapy. A Critical Evaluation (2002), Kluwer Academic Publishers, Dordrecht 79-107
4. Sies H. Oxidative stress: introductory remarks. In: Sies H. (Ed). Oxidative Stress (1985), Academic Press, London 18-28
5. Sies H. Oxidative stress: from basic research to clinical application. Am J Med 91 (1991) 3C/31S-3C/38S
6. Farber J.L., Kyle M.E., and Coleman J.B. Mechanism of cell injury by activated oxygen species. Lab Invest 62 (1990) 670-679
7. Jannsen Y.M.W., Van Houten B., Borm P.J.A., and Mossman B.T. Cell and tissue response to oxidative damage. Lab Invest 69 (1993) 261-274
8. Wiseman H., and Halliwell B. Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem J 313 (1996) 17-29
9. Poli G. Liver damage due to free radicals. Br Med Bull 49 (1993) 604-620
10. Powis G., Briehl M., and Oblong J. Redox signaling and the control of cell growth and death. Pharmacol Ther 65 (1995) 149-173
11. Lander H.M. An essential role for free radicals and derived species in signal transduction. FASEB J 11 (1997) 118-124
12. Nakamura H., Nakamura K., and Yodoi J. Redox regulation of cellular activation. Annu Rev Immunol 15 (1997) 351-369
13. Sen C.K. Redox signaling and the emerging therapeutic potential of thiol antioxidants. Biochem Pharmacol 55 (1998) 1747-1758
14. Ishii T., Itho K., Ruiz E., Bannai S., Yamamoto M., and Mann G.E. 4-Hydroxynonenal induces expression of antioxidant stress proteins via the transcription factor Nrf2 in cultured murine macrophages and vascular smooth muscle cells: lack of heme oxygenase-1, peroxiredoxin I and A170 induction in nrf2-knockout mice. J Physiol 531P (2001) 9
15. Conner E., Miles A.M., Aiko A., and Grisham M.B. Reactive oxygen metabolites. Therapeutic implications of their role in inflammatory diseases. Cell Immunother 3 (1995) 438-449
16. nd ed. (1989), Clarendon Press, Oxford
17. Favier A. Oxidative stress: value of its demonstration in medical biology and problems posed by the choice of markers. Ann Biol Clin 55 (1997) 9-16
18. Pryor W.A., and Godber S.S. Oxidative stress status: an introduction. Free Radic Biol Med 10 (1991) 173
19. Pryor A.A., and Godber S.S. Noninvasive measures of oxidative stress status in humans. Free Radic Biol Med 10 (1991) 177-184
20. Packer L. Oxygen radicals in biological systems. Methods Enzymol 233 (1994) (special issue)
21. Rice-Evans C., and Miller B.J. Total antioxidant status in plasma and body fluids. Methods Enzymol 234 (1994) 279-293
22. Nourooz-Zadeh J., Tajaddini-Sarmadi J., and Wolf S.P. Measurement of plasma hydroperoxide concentrations by the ferrous-oxidation xylenol orange (FOX) assay in conjunction with triphenylphosphine. Anal Biochem 220 (1994) 403-409
23. Alberti A, Bolognini L, Carratelli M, Della Bona MA, Macciantelli D. Assessing oxidative stress with the d-ROMs test. Some mechanistic considerations. Proceedings of the SFRR Europe Summer Meeting 26-28 June. Abana Terme, Italy; 1997. pp. 82-83.
24. Ahotupa A., Marniemi J., Lehtimaki T., Talvinen K., Raitakari O.T., Vasankari T., et al. Baseline diene conjugation in LDL lipids as a direct measure of in vivo LDL oxidation. Clin Biochem 31 (1998) 257-261
25. Levine R.I., Wehr N., Williams J.A., Stadman E.R., and Schacter F. Determination of carbonyl groups in oxidized proteins. Methods Mol Biol 99 (2000) 15-24
26. Uppu R.M., and Pryor W.A. The reactions of ozone with proteins and unsaturated fatty acids in reverse micelles. Chem Res Toxicol 7 (1994) 47-55
27. Pryor W.A., and Wu M. Ozonation of methyl oleate in hexane, in a thin film, in SDS micelles, and in distearoylphosphatidylcholine liposomes: yields and properties of the Criegee ozonide. Chem Res Toxicol 5 (1992) 505-511
28. Pryor W.A., and Uppu R.M. A kinetic model for the competitive reactions of ozone with amino acid residues in proteins in reverse micelles. J Biol Chem 268 (1993) 3120-3126
29. Squadrito G., Uppu R.M., Cueto R., and Pryor W.A. Production of the Criegee ozonide during the ozonation of 1-palmitoyl-2-oleoy-sn-glycero-3-phosphocholine liposomes. Lipids 27 (1992) 955-958
30. Uppu R.M., Cueto R., Squadrito G.L., and Pryor W.A. What does ozone react with at the air/lung interface? Model studies using human red blood cell membranes. Arch Biochem Biophys 319 (1995) 257-266
31. Pryor W.A., Squadrito G.L., and Friedman M. The cascade mechanism to explain ozone toxicity: the role of lipid ozonation products. Free Radic Biol Med 19 (1995) 935-941
32. Pryor W.A., Squadrito G.L., and Friedman M. A new mechanism for the toxicity of ozone. Toxicol Lett 82 (1995) 287-293
33. Wright D.T., Friedman M., Pryor W.A., Squadrito G.L., Salgo M.G., and Adler K.B. Lipid ozonation products activate phospholipases in guinea pig and human airway epithelial cells in vitro. Am J Resp Crit Care Med 49 (1994) A320
34. Bocci V. A reasonable approach for the treatment of HIV infection in the early phase with ozonetherapy (autohemotherapy). How inflammatory cytokines may have therapeutic role. Mediators Inflamm 3 (1994) 315-321
35. Bocci V. Ozone: a mixed blessing. Res Complementary Med 3 (1996) 25-33
36. Rietjens I.M., Lemminki H.H., Alink G.M., and van Bladeren P.J. The role of glutathione and glutathione S-transferases in fatty acid ozonide detoxification. Chem Biol Interact 62 (1987) 3-14
37. Hempenius R.A., de Vries J., and Rietjens I.M.C.M. Molecular orbital study on the glutathione-dependent detoxification of ozonides. Èur J Pharmacol Environ Toxicol Pharmacol Sect 228 (1992) 207-211
38. Commandeur J.N.M., Stijntjes G.J., and Vermeulen N.P.E. Enzymes and transport systems involved in the formation and disposition of glutathione S-conjugates. Pharmacol Rev 47 (1995) 271-330
39. van Bladeren P.J., and van Ommen B. The inhibition of glutathione S-transferases: mechanisms, toxic consequences and therapeutic benefits. Pharmacol Ther 51 (1991) 35-46
40. Jakoby W.B. The glutathione S-transferase: a group of multifunctional detoxification proteins. Adv Enzymol 46 (1978) 383-414
41. Vos R.M.E., Rietjens I.M.C.M., Stevens L.H., and Bladeren P.J.V. Methyl linoleate ozonide as a substrate for rat glutathione S-transferases: reaction pathway and isoenzyme selectivity. Chem Biol Interact 69 (1989) 269-278
42. Xie C., Lovell M.A., and Markesbery W.R. Glutathione transferase protects neuronal cultures against four hydroxynonenal toxicity. Free Radic Biol Med 25 (1998) 979-988
43. Hernández F., Menéndez S., Gómez M., and Eng L. Efecto de la ozonoterapia intravascular sobre el sistema de la glutation peroxidasa. Rev CENIC Ciencias Biol 20 (1989) 37-40
44. Hernández F., Menéndez S., and Wong R. Decrease of blood cholesterol and stimulation of antioxidative response in cardiopathy patients treated with endovenous ozone therapy. Free Radic Biol Med 19 (1995) 115-119
45. Hernández F., Calunga J.L., Turrent J., Menéndez S., and Montenegro A. Ozone therapy effects on biomarkers and lung function in asthma. Arch Med Res 36 (2005) 549-554
46. Larini A., Bianchi L., and Bocci V. The ozone tolerance. I., Enhancement of antioxidant enzymes is ozone dose-dependent in Jurkat-cells. Free Radic Res 37 (2003) 1163-1168
47. Beckett G.J., and Hayes J.D. Glutathione S-transferases: biomedical applications. Adv Clin Chem 30 (1993) 281-380
48. Aniya Y., and Anders M.W. Regulation of rat liver microsomal glutathione S-transferase activity by thiol/disulfide exchange. Arch Biochem Biophys 270 (1989) 330-334
49. Aniya Y., and Daido A. Organic hydroperoxide-induced activation of liver microsomal glutathione S-transferase of rats in vitro. Jpn J Pharmacol 62 (1993) 9-14
50. Scott M.D., Lubin B.H., Zuo L., and Kuypers F.A. Erythrocyte defense against hydrogen peroxide preeminent importance of catalase. J Lab Clin Med 118 (1991) 7-16
51. Eaton J.W. Catalases and peroxidases and glutathione and hydrogen peroxide: mysteries of the bestiary. J Lab Clin Med 118 (1991) 3-4
52. Fridovich I. Superoxide dismutase. Annu Rev Biochem 44 (1975) 147-159
53. Hernández F., Prats M., and González M. Un método simplificado para la determinación de superóxido dismutasa. Rev CENIC Ciencias Biol 25 (1994) 27-29
54. Pryor W.A. Mechanism of radical formation from reactions of ozone with target molecules in the lung. Free Radic Biol Med 17 (1994) 451-465
55. Pryor W.A. How far does ozone penetrate into the pulmonary air/tissue boundary before it reacts?. Free Radic Biol Med 12 (1992) 83-88
56. Wartanowicz M., Panczenko-Kresowska B., Ziemblanski S., Kowalska M., and Okolska G. The effect of α-tocopherol and ascorbic acid on the serum lipid peroxide level in elderly people. Ann Nutr Metab 28 (1984) 186-191
57. Vatassery G.T., Smith W.E., and Quach H.T. Ascorbic acid, glutathione and synthetic antioxidant prevent the oxidation of vitamin E in platelets. Lipids 24 (1989) 1043-1047
58. Pryor W.A. The antioxidant nutrients and disease prevention-what do we know and what do we need to find out?. Am J Clin Nutr 53 (1991) 391S-393S
59. Kaneko T., Kaji K., and Matsuo M. Protective effect of lipophilic derivatives of ascorbic acid on lipid peroxide-induced endothelial injury. Arch Biochem Biophys 304 (1993) 176-180
60. Frei B., Stocker R., and Ames B.N. Antioxidant defenses and lipid peroxidation in human blood plasma. Proc Natl Acad Sci USA 85 (1988) 9748-9752
61. Hernández F, Menéndez S, Alvarez I. Blood and tissue biochemical study of normo- and hypercholesterolemic rabbits treated with ozone. Proceedings of the 12th World Congress of the International Ozone Association. Lille, France; 1995. pp. 251-255.
62. Dormandy T. Free-radical oxidation and antioxidants. Lancet 1 (1978) 647-650
63. Gutteride J.M.C., and Halliwell B. The measurement and mechanism of lipid peroxidation in biological systems. TIBS 15 (1990) 129-135
64. Valenzuela A. The biological significance of malondialdehyde determination in the assessment of tissue oxidative stress. Life Sci 48 (1991) 475-477
65. Vasankari T., Kujala U., Heinonen O., Kapanen J., and Ahotupa M. Measurement of serum lipid peroxidation during exercise using three different methods: diene conjugation, thiobarbituric acid reactive material and fluorescent chromolipids. Clin Chim Acta 234 (1995) 63-69
66. Berlett B.S., Levine R.L., and Stadtman E.R. Comparison of the effects of ozone on the modification of amino acid residues in glutamine synthetase and bovine serum albumin. J Biol Chem 271 (1996) 4177-4182
67. Stadman E.R. Protein oxidation and aging. Science 257 (1992) 1220-1224
68. Wolf S.P. Ferrous ion oxidation in the presence of the ferric ion indicator xylenol orange for the measurement of hydoperoxides; the FOX assay. Methods Enzymol 233C (1994) 182-189
69. Nourooz-Zadesh J., Tajaddini-Sarmadi J., and Wolf S.P. Measurement of plasma hydroperoxide concentrations by the ferrous-oxidation xylenol orange (FOX) assay in conjunctions with triphenylphosphine. Anal Biochem 220 (1994) 403-409
70. Stadman E.R., and Oliver C.N. Metal calalyzed oxidation of proteins. Physiological consequences. J Biol Chem 256 (1991) 2005-2008
71. Stadman E.R., and Levine R.L. Protein oxidation. Ann NY Acad Sci 899 (2000) 191-208
72. Hu M.L. Measurement of protein thiol groups and glutathione in plasma. Methods Enzymol 233 (1994) 380-385
73. Arab K., and Steghens J.P. Plasma lipid hydroperoxides measurement by an automated xylenol orange method. Anal Biochem 325 (2004) 158-163
74. Dotan Y., Lichtenberg D., and Pinchuk I. Lipid peroxidation cannot be used as a universal criterion of oxidative stress. Prog Lip Res 43 (2004) 200-227
75. Arguelles S., García S., Maldonado M., Machado A., and Ayala A. Do the serum oxidative stress biomarkers provide a reasonable index of the general oxidative stress status?. Biochim Biophys Acta 1674 (2004) 251-259
76. Heinecke J.W. Method for the determination of oxidative stress. USA Patent (2000) 6096556
77. Kinkade Jr. J.M., Brown W.V., Pohl J., Shapira R., Jensen P.E., and Le N.A. Biomarkers for oxidative stress. PCT Patent WO (2000) 2000-028072
78. Lamb R.G. Test for oxidative stress using cell suspensions. PCT Patent WO (2000) 2000-000809
79. Ochi H., and Cutler R. Use of oxidative diagnostic plot as a health indicator for assessing oxidative stress and its control in humans. PCT Patent WO (1999) 1999-063341